Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.1 - $1.54 $22,345 - $31,283
20,314 New
20,314 $24,000
Q3 2018

Nov 14, 2018

SELL
$3.58 - $4.9 $47,016 - $64,351
-13,133 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$4.43 - $5.14 $98,771 - $114,601
-22,296 Reduced 62.93%
13,133 $63,000
Q1 2018

May 15, 2018

BUY
$4.65 - $5.9 $83,700 - $106,200
18,000 Added 103.28%
35,429 $184,000
Q4 2017

Feb 14, 2018

BUY
$4.32 - $5.52 $75,293 - $96,208
17,429
17,429 $81,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.